Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gynecologic Cancers
•
Palliation
What normal tissue dose constraints do you use when delivering up to 3 cycles of the palliative quad shot regimen for gynecologic pelvic malignancies?
Related Questions
Given the negative results of GOG-0238 but the positive results of the RUBY trial, how do you manage isolated vaginal cuff recurrence of endometrial cancer?
What is the optimal adjuvant vaginal brachytherapy schedule when a patient is getting concurrent chemotherapy?
How would you manage a patient with a high-risk asymptomatic bone metastasis with a driver mutation?
Is it safe to give spine SBRT after recent cryoablation?
Can patients receive Mona Lisa or other vaginal laser therapy for vaginal atrophy after pelvic radiation?
Would you ever start adjuvant pelvic radiation with a drain in place?
Is adenocarcinoma of the vulva more radioresistant than squamous cell carcinoma?
When do you add chemotherapy to post operative RT for vulvar carcinoma?
Is there a role for radiation in palliating malignant small bowel obstruction?
Do you use a comprehensive volumetric, rather than numeric, cutoff in consideration of SRS vs WBRT for brain metastases?
